Evidence map›Paper›PMID 22354849›Full record

ReviewJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2012

Osteocyte RANKL: new insights into the control of bone remodeling.

Jinhu Xiong, Charles A O'Brien

Registry-linked trialAbstract readReview
In one paragraph

Review in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02868554 (Orthodontic Tooth Movement With Accelerated Invisalign Therapy Using Acceledent Aura), which is not on this map. Cited by 131 papers.

0numbers the graph read from it
0cells of the map it votes in
131citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02868554 nacompletednot on this mapstarted 2016, after this paper: background citation

Orthodontic Tooth Movement With Accelerated Invisalign Therapy Using Acceledent Aura: A Randomized Clinical Trial

TypeinterventionalSponsorUniversity of North Carolina, Chapel HillRan2016 to 2019Enrolled34ConditionsMalocclusionArmsAcceleDent Aura, Accelerated Invisalign therapy
3 · Its place in the literature

Who cites it

131 citing papers in PubMed.

  1. Melorheostotic Bone Lesions Caused by Somatic Mutations in MAP2K1 Have Deteriorated Microarchitecture and Periosteal Reaction.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2019
    Trial
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Brain-Bone Axis in Physiological and Pathological Conditions.International journal of molecular sciences · 2025
    Review
  10. Adverse Outcome Pathways Applied to Space Radiation Research.Environmental and molecular mutagenesis · 2025
    Review
  11. Review
  12. Review
  13. Review
  14. P2YAging cell · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Bone equilibria and disruptions.Journal of the Pediatric Orthopaedic Society of North America · 2024
    Article
  20. Article

71 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jinhu XiongCenter for Osteoporosis and Metabolic Bone Diseases, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
Charles A O'Brien

Funding

TRANSGENIC MOUSE COREP01AG013918 · NIA · UNIV OF ARKANSAS FOR MED SCIS · PI WEINSTEIN, ROBERT STEWART · 1996 to 2016
$25.7M
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR029884 · NCRR · UNIV OF ARKANSAS FOR MED SCIS · PI LOWERY, CURTIS L · 2009 to 2011
$11.4M
Research Supplement to Promote Diversity in Health-related ResearchR01AR049794 · NIAMS · UNIV OF ARKANSAS FOR MED SCIS · PI CHARLES A O'BRIEN · 2003 to 2026
$6.3M
RANKL and lymphocyte-mediated bone lossI01BX000294 · VA · CENTRAL ARKANSAS VETERANS HLTHCARE SYS · PI O'BRIEN, CHARLES A · 2009 to 2022
–
BLRD VA I01 BX000294NCRR NIH HHS 1UL1RR029884NCRR NIH HHS UL1 RR029884NIAMS NIH HHS AR049794NIAMS NIH HHS R01 AR049794NIA NIH HHS AG13918NIA NIH HHS P01 AG013918
6 · The paper itself

Abstract

The idea that osteoblasts, or their progenitors, support osteoclast formation by expressing the cytokine receptor activator of NFkB ligand (RANKL) is a widely held tenet of skeletal biology. Two recent studies provide evidence that osteocytes, and not osteoblasts or their progenitors, are the major source of RANKL driving osteoclast formation in cancellous bone. The goal of this review is to highlight the results of these new studies and discuss their implications for our understanding of bone remodeling.

Indexed as

AnimalsBiomechanical PhenomenaBone RemodelingHormonesHumansOsteocytesRANK LigandHormonesRANK LigandTNFSF11 protein, human

Identifiers

PMID22354849
PMCPMC3449092

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.